This course is approved for 5.5 credits of continuing medical education (CME) by SynAptiv.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of SynAptiv and LearnHealth Inc. SynAptiv is accredited by the ACCME to provide continuing medical education for physicians.
SynAptiv designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credits. Physicians should claim the credit commensurate with the extent of their participation in the activity.
SynAptiv is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 16031 for 5.5 contact hours. Nurses should claim the credit commensurate with the extent of their participation in the activity.
GOAL & PURPOSE
With a focus on skin conditions seen commonly in the clinic, this conference will support primary care and other non-dermatology specialists who field dermatology related concerns on a regular basis to assist with diagnosis, management, and appropriate referrals to optimize patient care.
This live symposium is designed to meet the educational needs of:
Advanced Practice and Registered Nurses
Family Practice Physicians
DISCLOSURE OF CONFLICTS OF INTEREST
SynAptiv ensures balance, independence, objectivity, and scientific rigor in all our educational programs. In accordance with this policy, SynAptiv identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by SynAptiv to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis. SynAptiv is committed to providing its learners with high-quality activities that promote improvements or quality in healthcare and not the business interest of a commercial interest.
|Name of Faculty||Reported Financial Relationship|
Apple Bodemer, MD
|No financial relationships to disclose.|
|Cindy Chambers, MD MAS MPH||No financial relationships to disclose.|
|Danielle Tartar, MD PhD||No financial relationships to disclose.|
|Hadar Lev-Tov, MD MAS||Consulting Fees: Pfizer. Ownership Interest/Stock Holder: LearnSkin|
|Jason Ezra Hawkes, MD MS||Ownership Interest/Stock Holder: AbbVie, Gilead, Regeneron. Royalty: UpToDate. Honorarium: AbbVie, National Psoriasis Foundation, Novartis, Pfizer, VisualDx. Employee: Regeneron Pharmaceuticals (Spouse).|
|Jennifer Ornelas, MD MAS||No financial relationships to disclose.|
|Keira Barr, MD||No financial relationships to disclose.|
|Raja Sivamani, MD MS AP||Grants/Research Support: Regeneron Pharmaceuticals, AbbVie, Physicians Exculsive, Sytheon, Type A Deodorant. Consulting Fees: Regeneron Pharmaceuticals, Burt’s Bees, Arbonne. Ownership Interest/Stock Holder: LearnHealth – Spouse.|
|Vivian Shi, MD||Consulting Fees: Novartis, AbbVie|
The content and views presented in this educational activity are those of the speakers and do not necessarily reflect those of SynAptiv and LearnHealth Inc. The speakers have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.